Bioretec Ltd Inside information 9 September 2022 at 1.00 p.m. EET
"CORRECTION: Bioretec Ltd released a company announcement on 8 September 2022 at 5.00 p.m. EET . The announcement was missing information that it included inside information. The information that the annoucement includes inside information has been added to this corrective announcement on the basic data row. Additionally, the missing information on certified advisor contact information has been added into this corrective announcement."
TAMPERE, Finland , Sept. 9, 2022 /PRNewswire/ -- The European Patent Office has announced to approve Bioretec Oy's hybrid composite material patent application EP3782657A1 and will grant and publish the patent after the Company's confirmation.
Approved patent concerns magnesium-based reinforced composite material, i.e., hybrid composite. The patent also includes the usage of the hybrid composite material in the manufacturing of a medical device or a part of such a device.
The patented hybrid composite material will be used in those products of Bioretec's RemeOs™ product family that require very high load-bearing capacity. Targeted applications include intramedullary nails in the long bones of the upper and lower extremities and implants for spinal fusion. The hybrid composite material biodegrades in the body similarly as the RemeOs™ magnesium alloy material and is replaced by bone while promoting fracture healing, thus eliminating the need for implant removal surgery.
The patent application process for the hybrid composite material in regions outside of Europe continues based on the international PCT patent application WO2021032882A1, and the Company will inform about patent approvals in other regions as the application process progress.
Timo Lehtonen , CEO, p. +358 50 433 8493 Johanna Salko , CFO, p. +358 40 754 8172
Certified Adviser: Nordic Certified Adviser AB, tel. +46 70 551 67 29
Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of bioresorbable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.
Bioretec is developing the new RemeOs™ product line based on a magnesium alloy and hybrid composite, introducing a new generation of strong bioresorbable materials for enhanced surgical outcomes. The RemeOs™ implants are resorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their Value-Based Healthcare targets while focusing on value for patients through efficient healthcare. With the U.S. and EU market authorization for the first RemeOs™ product expected in 2022, Bioretec is positioning itself to enter the addressable USD 7 billion global orthopedic trauma market and become a game changer in surgical possibilities.
Better Healing - Better Life. www.bioretec.com.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/bioretec/r/correction--bioretec-s-hybrid-composite-patent-has-been-approved-in-europe,c3628631
View original content:https://www.prnewswire.com/news-releases/correction-bioretecs-hybrid-composite-patent-has-been-approved-in-europe-301621117.html
The FDA has approved Edwards Lifesciences Corp's (NYSE: EW) PASCAL Precision transcatheter valve repair system for transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation (DMR). TEER approximates the anterior and posterior mitral valve leaflets by grasping them with a clipping device, similar to a treatment developed in cardiac surgery called the Alfieri stitch. The PASCAL Precision system, with its grasping, atraumatic clasp and closure, and ability to elongate, enables s
Dr. Pervaiz Chaudhry has had a tumultuous decade in Fresno and in Pakistan. He sat with The Bee to talk about what has happened and what’s next.
OROVY, ESEA and FFBC made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 15, 2022.
Amazon's Buy With Prime program could boost its e-commerce dominance. But Google has refocused on using e-commerce-related searches to boost advertising growth.
Interest rate risk refers to changes in interest rates that could affect the market value of your bond or other fixed-income investments. This is a real concern for investors in any economic climate but is especially concerning during periods of … Continue reading → The post Interest Rate Risks: Investment Guide appeared first on SmartAsset Blog.
(Bloomberg) -- Elon Musk is demanding Twitter Inc. make the former head of its consumer division answer questions about spam or robot accounts on the social-media platform that are central to the billionaire’s legal fight to back out of a $44 billion buyout of the company. Most Read from BloombergAdobe Near Deal for Online Design Startup Figma, Sources SayRay Dalio Does the Math: Rates at 4.5% Would Sink Stocks by 20%Putin Acknowledges Xi’s ‘Concerns’ on Ukraine, Showing TensionAdobe Tumbles Aft
Shopify CEO Tobi Lutke just scooped up another $1.5 million of shares of cryptocurrency exchange Coinbase.
EVgo Inc. (EVGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
(Bloomberg) -- Beaming from behind laptops in the shadows of a lounge bar, Sanjay Jobanputra and Mark Brescacin strike a casual pose in the sole photo on an Instagram account linked to their company.Most Read from BloombergBezos Loses Spot as World’s Second-Richest Person to AdaniPatagonia Billionaire Who Gave Up Company Skirts $700 Million Tax HitGermany Tightens Control Over Industry With Russian Oil GrabPutin Acknowledges Xi’s ‘Concerns’ on Ukraine, Showing TensionAdobe Near Deal for Online D
(Bloomberg) -- The ascendant dollar is wreaking havoc across foreign-exchange markets as traders brace for the Federal Reserve to continue hiking interest rates aggressively.Most Read from BloombergBezos Loses Spot as World’s Second-Richest Person to AdaniPatagonia Billionaire Who Gave Up Company Skirts $700 Million Tax HitGermany Tightens Control Over Industry With Russian Oil GrabPutin Acknowledges Xi’s ‘Concerns’ on Ukraine, Showing TensionPutin Threatens New Military Strikes on Ukraine Infra
Texas Instruments Inc (NASDAQ: TXN) proposed raising its quarterly cash dividend by 8% to $1.24 per share and launching $15 billion in share repurchases in addition to $8.2 billion remaining under previous authorization. The dividend boost marks 19 consecutive years of dividend increases. In addition, as of Q2, TXN has reduced its outstanding shares by 47% through its share repurchases since the end of 2004. Sluggish sales of smartphones and personal computers have slowed demand for related chip
(Bloomberg) -- Traders are scurrying to hedge against potential gains in the yen, spurred by fears of intervention and uncertainty surrounding next week’s Bank of Japan policy meeting.Most Read from BloombergAdobe Near Deal for Online Design Startup Figma, Sources SayPutin Acknowledges Xi’s ‘Concerns’ on Ukraine, Showing TensionRay Dalio Does the Math: Rates at 4.5% Would Sink Stocks by 20%Germany Seizes Assets of Russian Oil Giant RosneftAdobe Tumbles After Deal to Buy Figma for About $20 Billi
"I estimate that a rise in rates from where they are to about 4.5 percent will produce about a 20 percent negative impact on equity prices," Bridgewater Associates' founder Dalio wrote in a LinkedIn post on Tuesday. The inflation data raised fears of another outsized interest rate hike next week and sent stock markets into a downward spiral.
EV startup Rivian is working through growing pains, amid rising raw material costs and chip shortages. Is Rivian stock a buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
How is Russia's oil industry doing under the weight of international sanctions? Not bad at all, according to the earnings of the biggest Kremlin-controlled oil major. Rosneft Oil said profits rose in the first half of the year, as rising crude prices helped Russia's state-backed energy giant and biggest taxpayer to shrug off mounting restrictions on exports. The company said net income rose 13% from a year earlier to 432 billion rubles, or around $7.2 billion. Fossil-fuel production rose 1.5% to
MercadoLibre stock had its Relative Strength (RS) Rating upgraded from 79 to 86 Friday. Is MercadoLibre Stock A Buy? MercadoLibre stock recently dipped below its 200-day moving average again and is not near a proper buy point right now, see if it manages to form and break out from a proper chart pattern.
CFRA Research says ESG is at a crossroad.
Apple's stock price has gained on average 1.6% one month after an iPhone launch, and sported a 14% gain six months after.
Two years ago, we did not get photographic proof of the white bear our daughter and I encountered on a trail in the Elkhorn Mountains in Western Montana. If anything, the inventory issue raised major concerns among investors, however, I am not sure a 40% drubbing was warranted.